WO2007006497A3 - Wirkstoffextrakt-solubilisate - Google Patents

Wirkstoffextrakt-solubilisate Download PDF

Info

Publication number
WO2007006497A3
WO2007006497A3 PCT/EP2006/006655 EP2006006655W WO2007006497A3 WO 2007006497 A3 WO2007006497 A3 WO 2007006497A3 EP 2006006655 W EP2006006655 W EP 2006006655W WO 2007006497 A3 WO2007006497 A3 WO 2007006497A3
Authority
WO
WIPO (PCT)
Prior art keywords
approximately
active ingredient
solubilsation
products
ingredient extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2006/006655
Other languages
English (en)
French (fr)
Other versions
WO2007006497A2 (de
Inventor
Dariush Behnam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aquanova AG
Original Assignee
Aquanova AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE102005032352A external-priority patent/DE102005032352A1/de
Priority claimed from DE200510056381 external-priority patent/DE102005056381A1/de
Priority claimed from DE102006024911A external-priority patent/DE102006024911A1/de
Application filed by Aquanova AG filed Critical Aquanova AG
Priority to EP06776151A priority Critical patent/EP1904042A2/de
Priority to US11/988,379 priority patent/US20080220102A1/en
Publication of WO2007006497A2 publication Critical patent/WO2007006497A2/de
Publication of WO2007006497A3 publication Critical patent/WO2007006497A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/005—Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
    • A23D7/0053—Compositions other than spreads
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/10—Foods or foodstuffs containing additives; Preparation or treatment thereof containing emulsifiers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Beschrieben wird ein Solubilisat eines einen physiologischen oder pharmazeutischen Wirkstoff enthaltenden Phytoextraktes, welches etwa 10 Gew% bis etwa 30 Gew% des Phytoextraktes, etwa 4 Gew% bis etwa 35 Gew% Wasser, das entionisiert, entmineralisiert oder einfach oder mehrfach destilliert sein kann, und etwa 55 Gew% bis etwa 75 Gew% eines Emulgators mit einem HLB-Wert von 9 - 16, bezogen auf das Solubilisat gleich 100 Gew%, enthält.
PCT/EP2006/006655 2005-07-08 2006-07-07 Wirkstoffextrakt-solubilisate Ceased WO2007006497A2 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP06776151A EP1904042A2 (de) 2005-07-08 2006-07-07 Wirkstoffextrakt-solubilisate
US11/988,379 US20080220102A1 (en) 2005-07-08 2006-07-07 Solubilsation Products of an Active Ingredient Extract

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DE102005032352A DE102005032352A1 (de) 2005-07-08 2005-07-08 Solubilisate pfanzlicher Wirkstoffe sowie Verfahren zur Herstellung der Solubilisate
DE102005032352.9 2005-07-08
DE102005056381.3 2005-11-24
DE200510056381 DE102005056381A1 (de) 2005-11-24 2005-11-24 Solubilisiertes Wirkstoff-Konzentrat
DE102006024911A DE102006024911A1 (de) 2006-05-24 2006-05-24 Boswellinsäure-Konzentrat
DE102006024911.9 2006-05-24

Publications (2)

Publication Number Publication Date
WO2007006497A2 WO2007006497A2 (de) 2007-01-18
WO2007006497A3 true WO2007006497A3 (de) 2007-07-26

Family

ID=37637517

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2006/006655 Ceased WO2007006497A2 (de) 2005-07-08 2006-07-07 Wirkstoffextrakt-solubilisate

Country Status (3)

Country Link
US (1) US20080220102A1 (de)
EP (1) EP1904042A2 (de)
WO (1) WO2007006497A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011049629A2 (en) 2009-10-22 2011-04-28 Api Genesis, Llc Methods of making and using compositions comprising flavonoids
US8637569B2 (en) 2009-10-22 2014-01-28 Api Genesis, Llc Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds
CN103327971A (zh) * 2010-10-22 2013-09-25 Api起源有限责任公司 提高难溶性化合物的溶解度的方法以及制备和使用这类化合物制剂的方法
KR101787076B1 (ko) * 2010-12-29 2017-10-18 주식회사 엘지생활건강 식물 유래 유체를 다량 함유하는 피부외용제
KR101897267B1 (ko) * 2010-12-29 2018-09-11 주식회사 엘지생활건강 식물 유래 유체를 다량 함유하는 피부외용제
KR101796295B1 (ko) 2010-12-29 2017-11-10 주식회사 엘지생활건강 식물 유래 유체를 다량 함유하는 피부외용제
DE202012012130U1 (de) * 2012-12-19 2014-03-21 Aquanova Ag Curcuminsolubilisat
US10779561B2 (en) 2016-06-14 2020-09-22 Aquanova Ag Resveratrol solubility
DK3651804T5 (da) * 2017-07-11 2023-10-09 Aquanova Ag Solubilisat med curcumin, boswellia og xanthohumol
KR102573152B1 (ko) * 2017-07-11 2023-09-01 아쿠아노바 아게 커큐민 및 선택적으로 적어도 1종의 다른 활성 물질을 갖는 가용화물
WO2019011414A1 (de) * 2017-07-11 2019-01-17 Aquanova Ag Solubilisat mit curcumin und boswellia
PL3820527T3 (pl) 2018-07-11 2024-01-03 Aquanova Ag Solubilizator ksantohumolu
CN112791017A (zh) * 2021-01-27 2021-05-14 四川梅奥由享生物科技有限公司 去皱修复美白的雨生红球藻胶束化提取物及其制备方法

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998003170A1 (en) * 1996-07-24 1998-01-29 Biosytes Usa, Inc. Method for enhancing dissolution properties of relatively insoluble dietary supplements and product incorporating same
DE10103454A1 (de) * 2000-12-29 2002-08-01 Aquanova Getraenketechnologie Wirkstoffkonzentrate sowie Verfahren zu ihrer Herstellung
WO2002085328A2 (de) * 2001-02-11 2002-10-31 Aquanova German Solubilisate Technologies (Agt) Gmbh Verfahren zur herstellung eines wirkstoffkonzentrats sowie wirkstoffkonzentrat
WO2004002469A1 (de) * 2002-06-29 2004-01-08 Aquanova German Solubilisate Technologies (Agt) Gmbh Isoflavonkonzentrate sowie verfahren zu ihrer herstellung
US20040192768A1 (en) * 2001-11-30 2004-09-30 Dariush Behnam Aqueous solution of ascorbic acid and method for producing same
WO2005056506A1 (de) * 2003-12-10 2005-06-23 Aquanova German Solubilisate Technologies (Agt) Gmbh Lutein-konzentrat

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003039583A1 (en) * 2001-11-08 2003-05-15 The Brigham And Women's Hospital, Inc. Lipoprotein lipase and lipoprotein lipase activators in the treatment of inflammatory conditions
DE10308162A1 (de) * 2003-02-26 2004-09-09 Universitätsklinikum Freiburg Verfahren zur Herstellung von Flavonoid-haltigen Zusammensetzungen und ihre Verwendung

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998003170A1 (en) * 1996-07-24 1998-01-29 Biosytes Usa, Inc. Method for enhancing dissolution properties of relatively insoluble dietary supplements and product incorporating same
DE10103454A1 (de) * 2000-12-29 2002-08-01 Aquanova Getraenketechnologie Wirkstoffkonzentrate sowie Verfahren zu ihrer Herstellung
WO2002085328A2 (de) * 2001-02-11 2002-10-31 Aquanova German Solubilisate Technologies (Agt) Gmbh Verfahren zur herstellung eines wirkstoffkonzentrats sowie wirkstoffkonzentrat
US20040192768A1 (en) * 2001-11-30 2004-09-30 Dariush Behnam Aqueous solution of ascorbic acid and method for producing same
WO2004002469A1 (de) * 2002-06-29 2004-01-08 Aquanova German Solubilisate Technologies (Agt) Gmbh Isoflavonkonzentrate sowie verfahren zu ihrer herstellung
WO2005056506A1 (de) * 2003-12-10 2005-06-23 Aquanova German Solubilisate Technologies (Agt) Gmbh Lutein-konzentrat

Also Published As

Publication number Publication date
US20080220102A1 (en) 2008-09-11
WO2007006497A2 (de) 2007-01-18
EP1904042A2 (de) 2008-04-02

Similar Documents

Publication Publication Date Title
WO2012065782A3 (de) Kollagenhydrolysat für die verwendung zur verbesserung der gesundheit der menschlichen haut, haare und/oder nägel
EP2168570A3 (de) Extrakte von Isochrysis sp.
WO2009074735A8 (fr) Utilisation d'un nouvel agent naturel dans des compositions cosmetiques
WO2007006497A3 (de) Wirkstoffextrakt-solubilisate
WO2008034764A3 (de) Kosmetische zubereitungen auf basis molekular geprägter polymere
WO2009101503A3 (fr) Utilisation de substances actives naturelles dans des compositions cosmétiques ou thérapeutiques
WO2007121352A3 (en) Therapeutic triterpenoids
WO2009103884A3 (fr) Composition pour l'alimentation humaine et/ou animale, ses utilisations, levures
WO2010000877A3 (en) Formulation with irritation reducing action comprising bisabolol and [6]-paradol
WO2010129285A3 (en) Antimicrobial compositions and related methods of use
WO2008087354A3 (fr) Gel creme comprenant au moins un retinoide et du péroxyde de benzoyle
WO2007045252A3 (en) An edible composition
WO2007113008A3 (en) Opaque container comprising food or pharmaceutical products or herbal(s)
WO2007113291A3 (en) Nutritional compositions for promotion of bone growth and maintenance of bone health and methods regarding same
TW200744661A (en) Topical cosmetic formulations for regulating and improving the moisture content of the skin
WO2012091440A3 (en) Composition for improvement, treatment and prevention of gastrointestinal motility disorders
WO2006112717A3 (en) Nutritional supplement for a category of hiv patients
WO2010046061A3 (de) Kosmetische und/oder pharmazeutische zubereitungen
WO2007053815A3 (en) Compositions and methods for organic juice based skin care products
WO2008148966A3 (fr) Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations
WO2011018763A8 (en) Combination of proanthocyanidins such as pycnogenol or grape seeds and centella asiatica for the treatment of cardiovascular disorders such as atherosclerosis
WO2009059755A3 (en) Novel neurturin conjugates for pharmaceutical use
WO2011042073A3 (de) Kosmetische oder dermatologische zubereitungen mit kombinationen aus öllöslichen kosmetischen oder dermatologischen wirkstoffen und einem oder mehreren bi- oder disulfiten
WO2006078699A3 (en) Oral care compositions derived from the labiatae family
WO2011055931A3 (ko) 인플루엔자 바이러스 유래 질병의 예방 또는 치료용 조성물

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 11988379

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

WWE Wipo information: entry into national phase

Ref document number: 2006776151

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 06776151

Country of ref document: EP

Kind code of ref document: A2

WWP Wipo information: published in national office

Ref document number: 2006776151

Country of ref document: EP